Patent ID: 11957384
Assignee: PROGENA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method of producing a peripheral blood mononuclear cell (“PBMC”) composition suitable for repairing or engineering a tissue comprising:
(a) selecting a patient in need of non-uterine tissue repair or engineering and obtaining PBMCs from the blood of the patient at least two months after an immune system influencing event or at least two months after an endocrine system influencing event,
(b) culturing the PBMCs in a culture medium, which contains human chorionic gonadotrophin or an HCG equivalent, in the presence of 4.8-6.0% carbon dioxide (CO2) for a time sufficient to produce PBMCs that enhance growth when contacted with the non-uterine tissue in need of repair or engineering in comparison to PBMCs not obtained or cultured according to (a) and (b).